Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study is designed to provide evidence of efficacy of cefiderocol in the treatment of serious infections in adult patients caused by carbapenem-resistant Gram-negative pathogens.
Epistemonikos ID: e01b49e2fe48062c981bc3693d11b47f24eca4bf
First added on: May 12, 2024